Teva Agrees to Settle 45-State Drug Price-Fixing Case

Teva Pharmaceutical Industries has reached an agreement in principle to settle a long-running price-fixing lawsuit brought by 45 states, Washington, D.C., and two U.S. territories. A federal judge in Connecticut paused the case while the parties work toward the settlement; its terms have not been disclosed, and the agreement does not establish an admission of guilt. The states alleged that Teva and other drugmakers conspired beginning in 2012 to raise prices on generic drugs, saying Teva increased prices on about 112 drugs and coordinated with competitors on at least 86, with some increases exceeding 1,000%.



